ICICI Lombard, United Breweries and Cipla Defy the Selloff as Nifty Hits 117-Session Low

While the Nifty 50 fell to a 117-session low Thursday, trading at levels not seen since April 7, 2026, ICICI Lombard, United Breweries and Cipla stood out by recording gains in an otherwise sweeping market decline that erased months of index appreciation.

• The Nifty 50 touched its lowest level in 117 sessions, reaching prices last seen on April 7, 2026
• ICICI Lombard, United Breweries and Cipla bucked the trend to post gains in the session
• Their outperformance highlights the defensive or idiosyncratic properties that shielded each from Thursday's shocks

A 117-session low on the Nifty 50 means Thursday's close erased approximately four months of index appreciation, returning the benchmark to its April 7 level. This type of significant index reset creates a natural analytical exercise: which stocks held their ground, and what does their resilience signal about investor preferences when macro and regulatory shocks collide? The three stocks identified — ICICI Lombard, United Breweries and Cipla — come from insurance, beverages, and pharmaceuticals respectively, sectors that share the property of demand inelasticity relative to economic cycles.

ICICI Lombard's ability to post a gain on a day when most insurance-adjacent stocks were obliterated by the IRDAI consultation paper is particularly notable. The distinction between a general insurer like ICICI Lombard and an insurance aggregation platform like PB Fintech matters here: IRDAI's proposed changes target commission structures in distribution channels, not the underwriting economics of the insurers themselves. ICICI Lombard as a product manufacturer rather than a distribution intermediary may face different — and more manageable — implications from the proposed reforms, justifying its relative outperformance.

United Breweries and Cipla represent the consumer-staples and healthcare defensive play that typically attracts rotation capital during broad market selloffs. Beverages consumption is relatively income-inelastic, and United Breweries' dominant position in Indian beer makes it a near-utility in consumer terms. Cipla's pharmaceutical revenues are similarly anchored in non-discretionary healthcare spending. As investors rotated out of rate-sensitive growth and financial stocks on Thursday, the staples-style characteristics of these two names made them natural beneficiaries of relative value reallocation, even as the broader Nifty reset to a four-month low.

Source: NDTV Profit. Single-source report; index level and stock performance per primary coverage.